PCMC
Paragon Capital Management (Colorado)’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,909
| Closed | -$238K | – | 217 |
|
|
2025
Q1 | $238K | Hold |
3,909
| – | – | 0.05% | 162 |
|
|
2024
Q4 | $221K | Hold |
3,909
| – | – | 0.04% | 165 |
|
|
2024
Q3 | $202K | Buy |
+3,909
| New | +$202K | 0.04% | 199 |
|
|
2023
Q3 | – | Sell |
-3,268
| Closed | -$209K | – | 191 |
|
|
2023
Q2 | $209K | Sell |
3,268
-394
| -11% | -$25.2K | 0.05% | 183 |
|
|
2023
Q1 | $254K | Sell |
3,662
-144
| -4% | -$9.98K | 0.06% | 119 |
|
|
2022
Q4 | $274K | Buy |
3,806
+4
| +0.1% | +$288 | 0.07% | 96 |
|
|
2022
Q3 | $270K | Buy |
3,802
+323
| +9% | +$22.9K | 0.08% | 81 |
|
|
2022
Q2 | $268K | Buy |
3,479
+5
| +0.1% | +$385 | 0.07% | 88 |
|
|
2022
Q1 | $254K | Buy |
3,474
+6
| +0.2% | +$439 | 0.05% | 118 |
|
|
2021
Q4 | $216K | Buy |
3,468
+5
| +0.1% | +$311 | 0.03% | 159 |
|
|
2021
Q3 | $205K | Buy |
3,463
+5
| +0.1% | +$296 | 0.04% | 164 |
|
|
2021
Q2 | $231K | Buy |
3,458
+5
| +0.1% | +$334 | 0.11% | 91 |
|
|
2021
Q1 | $218K | Buy |
3,453
+5
| +0.1% | +$316 | 0.11% | 94 |
|
|
2020
Q4 | $214K | Buy |
+3,448
| New | +$214K | 0.12% | 88 |
|
|
2018
Q4 | – | Sell |
-3,950
| Closed | -$245K | – | 199 |
|
|
2018
Q3 | $245K | Buy |
3,950
+1
| +0% | +$62 | 0.21% | 169 |
|
|
2018
Q2 | $219K | Buy |
3,949
+737
| +23% | +$40.9K | 0.19% | 187 |
|
|
2018
Q1 | $203K | Buy |
+3,212
| New | +$203K | 0.09% | 206 |
|
|
2017
Q4 | – | Sell |
-3,891
| Closed | -$248K | – | 190 |
|
|
2017
Q3 | $248K | Buy |
+3,891
| New | +$248K | 0.1% | 157 |
|